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Abstract
Scrapie is a naturally occurring transmissible spongiform encephalopathy of sheep and goats. There are
different strains of sheep scrapie that are associated with unique molecular, transmission, and phenotype
characteristics. However, in the United States, very little is known about the potential presence of scrapie
strains. Scrapie strain and PRNP genotype could both affect susceptibility, potential for transmission,
incubation period (IP), and control measures required for eliminating scrapie from a flock. The investigators
evaluated 2 US scrapie isolates, No. 13-7 and x124, after intranasal inoculation to compare clinical signs, IPs,
spongiform lesions, and patterns of PrPSc deposition in sheep with scrapie-susceptible PRNP genotypes
(QQ171). After inoculation with x124, susceptibility and IP were associated with valine at codon 136 (V136)
of the prion protein: VV136 sheep had short IPs (6.9 months), those in AV136 sheep were 11.9 months, and
AA136 sheep did not develop scrapie. All No. 13-7 inoculated sheep developed scrapie, with IPs of 20.1
months for AA136 sheep, 22.8 months for AV136 sheep, and 26.7 months for VV136 sheep. Patterns of
immunoreactivity in the brain were influenced by inoculum isolate and host genotype. Differences in PrPSc
profiles versus isolate were most striking when examining brains from sheep with the VV136 genotype.
Inoculation into C57BL/6 mice resulted in markedly different attack rates (90.5% for x124 and 5.9% for No.
13-7). Taken together, these data demonstrate that No. 13-7 and x124 represent 2 distinct strains of scrapie
with different IPs, genotype susceptibilities, and PrPSc deposition profiles.
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Infectious Disease–Original Article
Comparison of Two US Sheep Scrapie
Isolates Supports Identification
as Separate Strains
S. J. Moore1, J. D. Smith1, M. H. West Greenlee2, E. M. Nicholson1,
J. A. Richt1, and J. J. Greenlee1
Abstract
Scrapie is a naturally occurring transmissible spongiform encephalopathy of sheep and goats. There are different strains of sheep
scrapie that are associated with unique molecular, transmission, and phenotype characteristics. However, in the United States,
very little is known about the potential presence of scrapie strains. Scrapie strain and PRNP genotype could both affect sus-
ceptibility, potential for transmission, incubation period (IP), and control measures required for eliminating scrapie from a flock.
The investigators evaluated 2 US scrapie isolates, No. 13-7 and x124, after intranasal inoculation to compare clinical signs, IPs,
spongiform lesions, and patterns of PrPSc deposition in sheep with scrapie-susceptible PRNP genotypes (QQ171). After inocu-
lation with x124, susceptibility and IP were associated with valine at codon 136 (V136) of the prion protein: VV136 sheep had
short IPs (6.9 months), those in AV136 sheep were 11.9 months, and AA136 sheep did not develop scrapie. All No. 13-7
inoculated sheep developed scrapie, with IPs of 20.1 months for AA136 sheep, 22.8 months for AV136 sheep, and 26.7
months for VV136 sheep. Patterns of immunoreactivity in the brain were influenced by inoculum isolate and host genotype.
Differences in PrPSc profiles versus isolate were most striking when examining brains from sheep with the VV136 genotype.
Inoculation into C57BL/6 mice resulted in markedly different attack rates (90.5% for x124 and 5.9% for No. 13-7). Taken together,
these data demonstrate that No. 13-7 and x124 represent 2 distinct strains of scrapie with different IPs, genotype susceptibilities,
and PrPSc deposition profiles.
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lopathies
Scrapie is a naturally occurring transmissible spongiform ence-
phalopathy (TSE) of sheep and goats. Other TSEs include
bovine spongiform encephalopathy in cattle, chronic wasting
disease in cervids, and Creutzfeldt-Jakob disease in humans.
The central event in the pathogenesis of TSEs is the conversion
of the host-encoded cellular prion protein (PrPC) into its mis-
folded pathogenic form (PrPSc), which leads to neurodegenera-
tion and, eventually, death.
Strain traits arise from differences in the structure of the
misfolded protein.36 In the natural host, these strains may be
differentiated by incubation period (IP), clinical presentation,35
patterns of PrPSc immunoreactivity or microscopic lesions in
the brain,14 and the physiochemical properties of the PrPSc
itself.43 Inoculation of naturally occurring scrapie isolates into
inbred mouse strains has resulted in the identification of mul-
tiple strains of scrapie on the basis of IPs and lesion profiles.6,10
Susceptibility to scrapie is influenced by amino acid poly-
morphisms in the prion protein. In sheep, codons 136, 154, and
171 influence susceptibility to classical scrapie with 136 valine
(V), 154 arginine (R), and 171 glutamine (Q) (VRQ) being
associated with increased susceptibility, whereas 136 alanine
(A),11,25 154 histidine (H),28 and 171 arginine (R) (AHR)12,34
are associated with resistance to natural scrapie. Codon 171
appears to have the most discernible influence; sheep with
QQ171 are susceptible and those with RR171 are resistant.
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Very little is known about the number and diversity of scra-
pie strains present in the United States. In this report we
describe the clinical and pathologic findings in sheep experi-
mentally challenged via the intranasal route with 2 US scrapie
isolates. A previous study demonstrated that these isolates have
genotype-dependent differences in IP after inoculation by the
intracranial route.23 The purpose of this study was to compare
clinical signs, IPs, spongiform lesions, and patterns of PrPSc
deposition in sheep with scrapie-susceptible prion protein gene
(PRNP) genotypes to determine if inoculation with these scra-
pie isolates resulted in phenotypes that warrant consideration as
separate scrapie strains.
Materials and Methods
Ethics Statement
All animal experiments described were reviewed and approved
by the National Animal Disease Center’s Institutional Animal
Care and Use Committee (protocol nos. 3893 [sheep study] and
2414 [mouse bioassay study]) and were carried out in strict
accordance with the Guide for the Care and Use of Laboratory
Animals (Institute of Laboratory Animal Resources, National
Academy of Sciences, Washington, DC) and the Guide for the
Care and Use of Agricultural Animals in Research and Teach-
ing (Federation of Animal Science Societies, Champaign, IL).
Sources of Sheep Scrapie Inocula
The No. 13-7 inoculum was derived from a sheep receiving a
fourth intracranial serial passage through ARQ/ARQ Suffolk
sheep.19 The original inoculum No. 13-7 was prepared from a
pool of 13 brains from scrapie-affected ARQ/ARQ sheep (all
were positive by immunohistochemistry) from 7 source
flocks.22 The tissue was ground in a mechanical grinder, gen-
tamicin was added at a concentration of 100 mg/ml, and the
final concentration of 10% weight per volume was made with
phosphate-buffered saline.
The x124 inoculum was prepared from the brain of a Suffolk
sheep (ear tag no. 3004, genotype VRQ/ARR) from the Uni-
versity of Idaho scrapie flock that was challenged with the x124
scrapie brain pool inoculum.43 The original x124 inoculum was
prepared from a pool of 7 scrapie-affected sheep brains from 5
flocks obtained from the University of Idaho Caine Veterinary
Teaching Center, as described previously.8,23 All donor sheep
were PrPSc positive by immunohistochemistry and western blot
testing of the brain stem medulla at the level of the obex. The
PRNP genotypes at codons 136, 154, and 171 of the original
donor sheep were as follows: n ¼ 5 AARRQQ, n ¼ 1
AVRRQQ, and n ¼ 1 VVRRQQ.
Animal Procedures
At 4.5 months of age, recipient sheep from a scrapie-free flock
were intranasally (n ¼ 12) or intracranially (n ¼ 4) inoculated
with 1 ml of 10% suspension of either the No. 13-7 or x124
inocula.21 Inoculated sheep had polymorphisms at codon 136
(see Table 1) but were homozygous at positions 112 M, 127 H,
137 M, 141 L, 151 R, 154 R, 157 M, 171Q, 176 N, 180 H,
189Q, 195 T, 196 T, 211 R, 220Q and 223 R. Briefly, the
inoculum was drawn into a syringe and, without the aid of a
needle, squirted into the right nostril while the head was ele-
vated slightly. Inoculated animals were housed in a biosafety
level 2 containment facility for the initial 2 weeks postino-
culation (PI) and later were moved to outside pens at the
National Animal Disease Center. The sheep were fed pelleted
growth and maintenance rations that contained no ruminant
protein, and clean water was available ad libitum. Control
sheep were kept with the scrapie-free flock at the National
Animal Disease Center. Both groups were fed pelleted growth
ration and alfalfa hay. Animals were observed daily for the
development of clinical signs and euthanized on the develop-
ment of clinical signs consistent with scrapie or at the end of
the experiment (30 months PI).
Sample Collection and Processing
Rectal mucosal biopsies13 were collected from all sheep at
5 weeks PI and then at 3.5, 5, 6.5, 8, and 14months PI. A detailed
necropsy was carried out on each animal, and 2 sets of tissue
samples were collected. One set of tissues included representa-
tive sections of lymphoid tissues (palatine tonsil, pharyngeal
tonsil, and 3 rd eyelid), lymph nodes (LNs) (retropharyngeal,
mesenteric, renal, prescapular, and popliteal), nasal planum, ton-
gue, esophagus, reticulum, rumen, omasum, abomasum, intes-
tines (jejunum, ileum, and cecum), liver, spleen, kidney, urinary
bladder, pancreas, adrenal gland, thymus gland, thyroid gland,
pituitary gland, turbinates, trachea, lung, skin, striated muscles
(heart, tongue, diaphragm, masseter, biceps femoris, and psoas
major), eye (including retina), nerves (optic, sciatic, and vagus),
trigeminal ganglion, spinal cord (cervical, thoracic, and lumbar),
and brain (cerebral cortex, cerebellum, midbrain including
superior colliculus, and brain stem including obex). These tissues
were fixed in 10% buffered formalin, embedded in paraffin wax,
sectioned at 4 mm, and stained with hematoxylin and eosin for
light microscopy. The second set of tissues was frozen.
All paraffin-embedded tissues were stained by an automated
immunohistochemical method for detection of PrPSc as
described previously16 with a cocktail of 2 monoclonal anti-
bodies, F89/160.1.533 and F99/97.6.1,39 each used at a concen-
tration of 5 mg/ml.
The frozen portion of brain was used for immunodetection
of PrPres by a commercial western blot (Prionics Check west-
ern blot; Prionics AG, Schlieren, Switzerland) as described
previously16 and developed with monoclonal antibody P4
(Rida mAb P4; R-Biopharm AG, Darmstadt, Germany), which
targets amino acids 89 to 104 of the ovine prion protein
sequence24 at a 1:10,000 dilution (0.1 mg/ml).
PrPSc Short Profiles
PrPSc short profiles that can be used to compare and differenti-
ate TSE strains in sheep by quantifying the morphologic type
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and distribution of PrPSc deposits were recorded as described
previously.30 Briefly, the morphology of PrPSc deposits in the
brain depends on the subcellular location of PrPSc and the cell
type affected.14,15 Intracellular PrPSc deposit types include
intraneuronal, intramicroglial, and intra-astrocytic. Extracellu-
lar accumulations include stellate, subpial, perivascular, peri-
vacuolar, particulate/coalescing, perineuronal, linear,
nonvascular plaques, and vascular plaques. PrPSc deposits may
be associated with the gray matter neuropil (linear, perineur-
onal, particulate/coalescing), neurons (intraneuronal), micro-
glial cells (intramicroglial), astrocytes (intra-astrocytic), and
astrocyte processes that form the glial limitans (subpial, sub-
ependymal, perivascular), or glial cells of uncertain origin
(stellate, perivacuolar). Plaques are fibrillar, radiate, relatively
large accumulations of PrPSc that are termed vascular plaques
when they are unequivocally distributed around blood vessels
and nonvascular plaques when they are not.14 For each of 11
neuroanatomic areas in the corpus striatum (basal nuclei and
frontal cortex), the magnitude of PrPSc accumulation associ-
ated with each of the above 12 morphologic labeling types was
scored on a scale of 0 to 3 (see Gonzalez et al15 for pictorial
examples of each score). The resulting PrPSc profiles were
compared between animals in this study.
Mouse Bioassay
To further characterize the No. 13-7 and x124 isolates, they
were inoculated into C57BL/6 mice after isoflurane anesthesia
as previously described.38 Mice (n ¼ 23 for x124, n ¼ 21 for
No. 13-7) were concurrently inoculated by the intracranial
(20 ml) and intraperitoneal (100 ml) routes using the same
10% brain homogenate as used in sheep. Mice were monitored
daily for the development of clinical signs by animal care staff
members. When signs suggestive of prion disease such as
ataxia, listing or rolling gate, pelvic limb paresis, lethargy, or
poor grooming with urine-stained fur were recognizable by
observation, animals were humanely euthanized and their
brains prepared for analysis by western blot for the identifica-
tion of PrPSc as described above except using monoclonal anti-
body 6H4 (Prionics AG) at a 1:10,000 dilution (0.1 mg/ml).
IPs are expressed as days PI. All animals that died of inter-
current disease or without the development of clinical signs 2
standard deviations or less prior to the average incubation time
were included in the calculation of attack rate. Using these
criteria to calculate attack rate, 21 mice were included in the
x124 inoculation group, and 17 mice were used for the No. 13-7
group. Survival analysis was done using GraphPad Prism 6 for
Mac OSX (GraphPad Software, San Diego, CA).
Results
All sheep challenged with isolate No. 13-7 developed clinical
disease. Mean IPs for AA136 sheep (20.1 months) were shorter
than for AV136 (22.8 months) and VV136 (26.7 months) sheep
(see Table 1). Of the sheep challenged with x124 inoculum, 4
of 6 developed disease during the project. The mean IP for
VV136 sheep (n ¼ 2) was 6.9 months and for AV136 sheep
(n ¼ 2) was 11.9 months. IPs of sheep challenged with x124
were significantly shorter than those challenged with No. 13-7
(Welch 2-sample t test, P < 0.01). Neither sheep of the AA136
genotype inoculated with isolate x124 developed clinical signs
consistent with scrapie: 1 AA136 sheep was euthanized at 16.6
months PI because of intercurrent disease, and a second did not
develop clinical disease and was euthanized at the end of the
project (30 months PI). Clinical signs observed in both inocu-
lated groups included reluctance to stand, hindlimb weakness,
and stumbling. Clinical signs consistent with pruritus (eg, rub-
bing and nibbling at the hind legs and flanks and loss of wool
over the hipbones) were observed only in VV136 or AV136
sheep challenged intranasally with x124.
Preclinical PrPSc accumulation, assessed using rectal muco-
sal (RAMALT) biopsy, was first detected at the 6.5 months PI
in a VV136 sheep inoculated intranasally with x124. This
sheep was euthanized because of severe clinical disease
2 weeks later. None of the remaining animals (including intra-
cranially inoculated AA136 positive control animals) were pos-
itive at the 8-month PI sampling. At the 14-month PI sampling,
5 of 6 No. 13-7 intranasally inoculated sheep were positive, as
were both x124 intracranially inoculated sheep of the AA136
genotype. RAMALT samples collected at necropsy were
strongly positive for all No. 13-7 challenged animals and
VV136 x124 animals. One AV136 sheep challenged with
x124 was negative, and the other was weakly positive. Both
AA136 sheep challenged intranasally with x124 were negative
in all RAMALT samples collected.
Widespread PrPSc accumulation in non–central nervous
system tissues was observed in all challenged sheep with the
exception of the 2 AA136 x124 intranasally inoculated sheep,
which were negative on all tissues examined. The esophagus,
diaphragm, liver, lung, trachea, turbinate, nasal planum, thymus,
thyroid, and urinary bladder were negative in all sheep. A sum-
mary of the results for other tissues can be found in Table 1.
In positive lymphoid tissues of the head (palatine tonsil,
pharyngeal tonsil, 3 rd eyelid, and retropharyngeal LN),
abdominal LNs (mesenteric LN, renal LN), gut-associated lym-
phoid tissue (GALT) (jejunum, ileum, caecum, RAMALT),
peripheral LNs (prescapular LN, popliteal LN), and spleen, the
PrPSc immunolabeling pattern consisted of fine to coarse gran-
ules of PrPSc in tingible body macrophages with or without
reticular labeling of follicular dendritic cells.41
Immunolabeling of the enteric nervous system (ENS) man-
ifested as fine granules of PrPSc within the cytoplasm of neu-
rons and glial cells and, occasionally, deposition of PrPSc on the
cell membrane of enteric neurons of the myenteric (Auer-
bach’s) plexus and submucosal (Meissner’s) plexus.42 In fore-
gut tissues, ENS labeling was the only type of immunolabeling
seen: the reticulum was positive in 1 sheep (No. 13-7 intracra-
nial AA136); the rumen was positive in 1 sheep (No. 13-7
intranasal VV136), and this animal was also positive in the
abomasum; and the omasum was positive in 4 sheep (n ¼ 2
x124 intranasal VV136, n ¼ 1 No. 13-7 intranasal AV136, n ¼
1 No. 13-7 intranasal AV136).
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In the intestines (jejunum, ileum, cecum), immunolabeling
of GALT and ENS was variably present. Both GALT and ENS
immunolabeling were observed concurrently in all (n ¼ 6)
No. 13-7 intranasally inoculated sheep and x124 intranasally
inoculated VV136 sheep. The ENS was negative in x124 intra-
nasally inoculated AA136 sheep and No. 13-7 intracranially
inoculated AA136 sheep. In x124 intranasally inoculated
AV136 sheep, the ENS was positive in 1 of 2 animals, but
insufficient tissue was available to assess GALT. In x124
intracranially inoculated AA136 sheep, the ENS was positive
(n ¼ 2) and GALT positive (n ¼ 1) or negative (n ¼ 1).
Positive immunolabeling in the peripheral nervous system
(optic nerve, sciatic nerve, vagus nerve, trigeminal ganglion)
presented as punctate deposits in ganglion cells and/or satellite
cells.17 The plexiform layers of the retina contained confluent
accumulations, and multifocal punctate immunolabeling was
seen in the photoreceptor, nuclear, and ganglion cell layers.
The location and morphology of PrPSc immunolabeling in the
tongue was consistent with accumulation in the sensory nerve
fibers in the core of the lingual papillae.32
In skeletal muscle (biceps femoris, masseter, psoas major),
immunoreactivity was observed as punctate deposits in cells of
the neuromuscular spindles (Figure 1).1 In the adrenal gland,
granular immunolabeling was observed in the chromaffin cells
of the adrenal medulla (Figure 2).29 In the pituitary, granular
immunolabelingwas present in thepars intermedia andnervosa.37
Genotype appeared to have an effect on the PrPSc profile in
No. 13-7 inoculated animals (Figure 3). PrPSc profiles for
AA136 and AV136 sheep were similar. In contrast, PrPSc pro-
files for VV136 sheep featured relatively prominent and wide-
spread intracellular immunolabeling types, in particular intra-
astrocytic and intramicroglial labeling, and relatively less glial
membrane associated labeling types stellate, subpial, perivas-
cular, and perivacuolar (Figures 4–7).
PrPSc profiles for AA136 sheep challenged with No. 13-7
via the intranasal or intracranial route were broadly similar.
However, a small reduction in the magnitude of intra-
astrocytic and intramicroglial labeling types was observed in
intracranially challenged sheep (Figure 3).
PrPSc was not detected in the brains or other tissues of the 2
AA136 sheep inoculated intranasally with x124. PrPSc profiles
for VV136 and AV136 sheep challenged with this isolate were
broadly similar, although AV sheep had relatively less intra-
astrocytic and intramicroglial immunolabeling. Intracranially
challenged sheep had less subpial labeling (Figure 8).
Figure 3. PrPSc profiles for sheep challenged with the No. 13-7
inoculum. IC, intracranial challenge; IN, intranasal challenge. Genotype
at codon 136: A, alanine; V, valine. PrPSc types: ITNR, intraneuronal;
ITAS, intra-astrocytic; ITMG, intramicroglial; STEL, stellate; SBPL,
subpial; PRVS, perivascular; PVAC, perivacuolar; PART, particulate/
coalescing; PNER, perineuronal; LINR, linear; NVPL, nonvascular
plaques; VSPL, vascular plaques.
Figure 1. Skeletal muscle, sheep. Coarse, granular PrPSc immunoreactivity in cells of the neuromuscular spindle. Immunohistochemistry for
PrPSc. Figure 2. Adrenal gland, sheep. Coarse, granular PrPSc immunoreactivity of the chromaffin cells of the adrenal medulla (right of photo)
and absence of immunoreactivity in cells of the adrenal cortex (left of photo). Immunohistochemistry for PrPSc.
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Inoculum appeared to have an effect on PrPSc profiles for
VV136 and intracranially challenged AA136 sheep. When con-
sidering VV136 sheep, those inoculated with No. 13-7 had
relatively more intracellular labeling (intraneuronal, intra-
astrocytic, intramicroglial), less glial membrane associated
labeling (stellate, subpial, perivascular, perivacuolar), and less
neuropil labeling (particulate) than those inoculated with x124
(Figure 9). In contrast, PrPSc profiles for AV136 sheep were
similar for both inocula (Figure 10). A comparison could not be
made for intranasally challenged AA136 sheep, because x124
Figures 4–7. Scrapie, brain, sheep. Immunohistochemistry for PrPSc, monoclonal antibody F99/97.6.1. Figure 4. AV136 sheep inoculated with
No. 13-7. There is prominent linear and coarse granular PrPSc immunoreactivity in the neocortex and perivascular glial-associated labeling in the
white matter. Figure 5. AA136 sheep inoculated with No. 13-7. There is prominent stellate labeling (arrowheads) in addition to linear and
coarse granular PrPSc immunoreactivity in the neocortex and perivascular glial-associated labeling in the white matter. Figure 6. VV136 sheep
inoculated with No. 13-7. PrPSc immunoreactivity is much less extensive than in AV136 sheep (Figure 4) or AA136 sheep (Figure 5). Intraneur-
onal, intra-astrocytic, and intramicroglial labeling types are prominent, while linear, coarse granular, and stellate labeling types are absent.
Figure 7. VV136 sheep inoculated with No. 13-7. Higher magnification view of area shown in Figure 6. Note that immunoreactivity comprises
only intraneuronal, intra-astrocytic, and intramicroglial labeling types.
1192 Veterinary Pathology 53(6)
challenged sheep did not accumulate PrPSc in the brain (Figure
11). However, for intracranially challenged AA136 sheep,
sheep inoculated with x124 had more intraglial labeling
(intra-astrocytic, intramicroglial) and less glial membrane
labeling (stellate, subpial, perivacuolar) than sheep challenged
with No. 13-7 (Figure 12).
Molecular profiles obtained from western blot of brain
homogenates from all sheep were similar regardless of inocu-
lum used or genotype of sheep (Figure 13).
The No. 13-7 and x124 inocula had significantly different
effects in C57BL/6 mice (P < .0001). The attack rate for the
x124 inoculum was 90.5% (19 of 21 mice), whereas the attack
rate for No. 13-7 was 5.9% (1 of 17 mice). The mean incubation
time for the x124 inoculum was 557 days, whereas the incuba-
tion time for the single positive animal inoculated with No. 13-
7 inoculum was 907 days (Figure 14).
Discussion
This study provides further characterization of the phenotype
of the No. 13-7 and x124 US scrapie isolates in sheep after
intranasal challenge. This work presents evidence for 2 distinct
scrapie strains in US sheep on the basis of differences in clin-
ical signs, genotypes of susceptible sheep, IPs, and lesion pro-
files in genotype-matched experimental groups of sheep and
attack rates and incubation times on mouse bioassay.
There were differences in clinical signs demonstrated by
sheep receiving the different inocula in the present study. In
sheep inoculated intranasally with x124 inoculum, clinical
signs of pruritus (eg, itching, biting, and wool loss) were
observed, but not in those challenged intranasally with No.
13-7. Lack of obvious pruritus or loss of wool was previously
reported for the No. 13-7 inoculum after oral and intracranial
challenge.19,20 Interestingly, intracranial challenge with x124
did not lead to pruritus,23 consistent with the results reported in
the present study. Mild pruritus was observed rarely following
oral challenge with x124.8
All sheep used in this study were homozygous Q171 and
considered to be scrapie susceptible. However, the amino acid
at codon 136 played a major role in IP differences between
sheep inoculated with either the x124 or No. 13-7 inoculum.
IPs in sheep inoculated with x124 were markedly shorter than
those in sheep challenged with No. 13-7. These observations
are consistent with previous results.8,23 Interestingly, PrPSc was
not detected in sheep of the AA136 genotype challenged intra-
nasally with x124. In contrast, AA136 sheep inoculated intra-
cranially with x124 accumulated PrPSc in their lymphoid tissue
and developed clinical disease, but with prolonged IPs relative
to sheep carrying the V136 codon. The susceptibility of AA136
sheep to intracranial23 but not intranasal challenge suggests
that initial replication of PrPSc may be inefficient in the per-
iphery of sheep with the AA136 genotype or that perhaps a
higher dose of inoculum would be required to infect sheep of
this genotype. The shorter IP observed with the x124 inoculum
correlates with a lower stability of PrPSc as determined by
unfolding in guanidine hydrochloride.43
A similar trend in the IPs produced by the x124 and No. 13-7
inocula was observed on mouse bioassay. IPs for mice chal-
lenged with the x124 isolate were significantly shorter than for
mice challenged with the No. 13-7 isolate. In addition, the
attack rate of the x124 isolate (90.5%) was significantly higher
than that of the No. 13-7 isolate (5.9%). Therefore mouse
bioassay results further support the designation of x124 and
No. 13-7 as distinct strains of the sheep scrapie agent.
In previous studies, the No. 13-7 inoculum has been used to
challenge sheep by the intracranial,18–20 intralingual,18 oral,20
intranasal,21 peritoneal,21 and conjunctival21 routes, and the
x124 inoculum was shown to result in rapid incubation times
in sheep with the V136 codon after oral or intracranial inocu-
lation.8,23 In the present study, IPs after intranasal inoculation
with the x124 inoculum were similar to those previously
reported for oral challenge8 but were longer than after intracra-
nial challenge. The mean IP for x124 intranasally challenged
AV136 sheep (11.9 months PI) reported in the present study is
similar to that reported for AV136 sheep challenged orally with
the x124 inoculum at birth (10.2 months PI) or 9 months of age
(12.6 months PI).8 This suggests that passage of x124 in
AV136 sheep does not markedly alter its phenotype, at least
with regard to IP in AV136 sheep. With regard to the x124
inoculum used here that is derived from a single animal chal-
lenged with the x124 isolate,43 it is difficult to form a direct
comparison with the results of previous studies in which the
inoculum was derived from a pool of brains from scrapie
affected sheep of different genotypes.8,23
With the exception of AA136 sheep inoculated with x124
(which did not develop scrapie), there was widespread distri-
bution of PrPSc immunoreactivity in non–central nervous sys-
tem tissues in all sheep. For x124 inoculated animals, PrPSc was
detected in the tongue only in the 2 AA136 sheep inoculated
intracranially. The location and morphology of PrPSc immuno-
labeling in these animals was consistent with accumulation in
Figure 8. PrPSc profiles for sheep challenged with the x124 inoculum.
IC, intracranial challenge; IN, intranasal challenge. Genotype at codon
136: A, alanine; V, valine. PrPSc types: ITNR, intraneuronal; ITAS, intra-
astrocytic; ITMG, intramicroglial; STEL, stellate; SBPL, subpial; PRVS,
perivascular; PVAC, perivacuolar; PART, particulate/coalescing;
PNER, perineuronal; LINR, linear; NVPL, nonvascular plaques; VSPL,
vascular plaques.
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the sensory nerve fibers in the core of the lingual papillae,32 as
reported previously for 7 of 10 naturally infected ARQ/ARQ
sheep in Italy.9 Of the animals challenged with No. 13-7, PrPSc
was only observed in the tongue of 1 intranasally challenged
VV136 sheep. The absence of PrPSc in the tongue from ARQ/
ARQ sheep is consistent with a previous study in which PrPSc
was not detected in the tongue from ARQ/ARQ sheep
inoculated intralingually (n ¼ 3) or intracranially (n ¼ 5) with
the No. 13-7 inoculum.18 Anterograde spread of prions from
the brain to the tongue along tongue-associated cranial nerves,
and retrograde spread from the tongue to the brain, has been
reported for hamsters inoculated with transmissible mink
Figure 13.Western immunoblot of brain stem samples from scrapie-
inoculated sheep developed using monoclonal antibody P4 to detect
PrPres Lane key: M, molecular mass marker. 1 and 2, VV136 sheep
challenged intranasally with No. 13-7 (lane 1, case #10) or x124 (2,
case #2). 3 and 4, AV136 sheep challenged intranasally with No. 13-7
(3, case #11) or x124 (4, case #3). 5 and 6, AA136 sheep challenged
intranasally with No. 13-7 (5, case #13) or x124 (6, case #5). 7 and 8,
AA136 sheep challenged intracranially with No. 13-7 (7, case #15) or
x124 (8, case #8).
Figure 14. Survival time of C57BL/6 mice inoculated with x124
(n¼ 23) and No. 13-7 (n¼ 21) sheep scrapie isolates. Mice inoculated
with x124 (solid line) developed scrapie, with a mean incubation of
557 days and an attack rate of 90.5%. Only a single mouse inoculated
with No. 13-7 (dashed line) developed scrapie, with an incubation
period of 907 days.
Figures 9–12. PrPSc profiles for VV136 sheep (Figure 9) and AV136 sheep (Figure 10) challenged intranasally and for AA136 sheep challenged
intranasally (Figure 11) or intracranially (Figure 12). IC, intracranial challenge; IN, intranasal challenge. PrPSc types: ITNR, intraneuronal; ITAS,
intra-astrocytic; ITMG, intramicroglial; STEL, stellate; SBPL, subpial; PRVS, perivascular; PVAC, perivacuolar; PART, particulate/coalescing;
PNER, perineuronal; LINR, linear; NVPL, nonvascular plaques; VSPL, vascular plaques.
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encephalopathy.2,3 Detection of PrPSc in tongues from both
intranasally and intracranially challenged animals in the pres-
ent study suggests that similar mechanisms exist in sheep.
Profiling of PrPSc immunoreactivity patterns further sup-
ports differences between these 2 scrapie strains. Among No.
13-7 inoculated sheep, the PrPSc profile of VV136 sheep was
clearly different from other codon 136 genotypes in this group
(AV, AA). VV136 sheep inoculated with No. 13-7 had rela-
tively more intraneuronal labeling, less glial membrane–asso-
ciated labeling, and less neuropil labeling than sheep
inoculated with x124. Similar to sheep inoculated with No.
13-7, VV136 sheep inoculated with x124 had more intra-
astrocytic and intramicroglial labeling than AV136 sheep.
However, in contrast to the No. 13-7 challenged sheep, the
amounts of glial membrane and neuropil labeling were similar
in x124 intranasally challenged VV136 and AV136 sheep.
Because the AA136 sheep inoculated with x124 did not
develop scrapie, it was not possible to obtain a profile for these
sheep.
Different routes of inoculation have previously been shown
to result in differences in the magnitude of immunolabeling in
sheep, although the overall shape of the PrPSc profiles curve is
usually conserved.15 Given that the overall shape of the PrPSc
profile curves for AA136 sheep challenged intracranially or
intranasally with No. 13-7 are similar for all labeling types
except intra-astrocytic and intramicroglial, it is likely that the
apparent reduction in magnitude of these 2 labeling types only
in intracranially challenged sheep is the result of magnification
of individual variation effects by small group sizes. Repeating
the challenge with larger group sizes could help resolve this
issue.
PrPSc profiles for the No. 13-7 and x124 inocula were sim-
ilar in intranasally challenged AV136 sheep but distinctly
different in intranasally challenged VV136 sheep and intra-
cranially challenged AA136 sheep. These observations are
likely to be the result of agent strain versus host genotype
interactions.
The No. 13-7 inoculum has been passaged in AA136 sheep,
while the x124 inoculum was prepared from the brain of a
VRQ/ARR (codons 136, 154, and 171) sheep that had been
challenged with a mixed-genotype brain pool. In QR171 sheep
with scrapie, more than 90% of the PrPSc is composed of the
Q171 allelotype, as the ARR allelotype has low conversion
efficiency for PrPSc.26 In sheep, the V136 codon does not occur
on the same allele as the R171 codon. Therefore, the PrPSc in
the No. 13-7 inoculum was ARQ and that of x124 was VRQ.
Conversion efficiencies in cell culture and in vitro assays
can be used to infer interactions between PrPSc and PrPC pro-
teins from sheep of different genotypes. Conversion is more
likely to occur7,40 and to be more efficient4,5,27 with a homo-
zygous inoculum-substrate combination (eg, inoculum from
sheep with the VRQ [PrPSc-VRQ] allele to susceptible VRQ
[PrPC-VRQ] sheep) than with a heterozygous combination (eg,
VRQ inoculum to ARQ sheep). Using in vitro conversion
assays, inocula from 6 VRQ/VRQ sheep naturally infected with
scrapie were not able to amplify in a substrate derived from the
brains of scrapie-free ARQ/ARQ sheep, while 3 of 6 ARQ/
ARQ isolates were able to amplify in either ARQ and VRQ
substrates.40 The x124 inoculum causes disease in intracra-
nially challenged, but not intranasally challenged, AA136
sheep. This suggests that although the x124 inoculum is able
to convert PrPC-ARQ, it does so with a low conversion effi-
ciency but that this barrier can be overcome by inoculation via
the intracranial route.
With regard to VRQ/ARQ heterozygous sheep, cell free
conversion assays have shown that PrPSc-VRQ/ARQ converts
PrPC-VRQ at least 3 times as efficiently as to PrPC-ARQ.4 In vivo,
purified PrPC from scrapie-affected sheep was found to contain
equivalent amounts of PrPC-VRQ and PrPC-ARQ, while PrPSc
from the same sheep contained 75% PrPSc-VRQ and only 25%
PrPSc-ARQ.31 This preferential accumulation of PrPSc-VRQ, pre-
sumably regardless of inoculum genotype, may explain why
PrPSc profiles for No. 13-7 and x124 are similar in 136AV
sheep. The longer IPs observed in No. 13-7 intranasally chal-
lenged 136AV sheep compared with x124 challenged 136AV
sheep could be due to less efficient conversion of PrPC-VRQ/ARQ
by PrPSc-ARQ than by PrPSc-VRQ.
Conclusions
The results of the present study, based on differences between
these 2 inocula with regards to clinical signs, genotype suscept-
ibilities, IPs, and PrPSc profiles observed in sheep, and on IPs
and attack rates in wild-type mice support the fact there are at
least 2 strains of scrapie present in the US national flock. Dif-
ferent strains may require additional consideration when
addressing potential transmission within a flock or control
measures applied on a national basis.
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